The Genome Editing/Genome Engineering Market Size is valued at 5900.0 Million in 2022 and is predicted to reach 28469.3 Million by the year 2031 at a 19.20 % CAGR during the forecast period for 2023-2031.
Genome engineering is the technique that involves gene modification by certain process include DNA is insertion, cutting, modification or replacement of genome of a living organism. Due to increasing the research and development spend by companies and organization fueling the highest growth of genome engineering market.
Advancement in genomic technologies helping research organizations to take deep dive in genome engineering hence companies are making significant investment in Research and development. For instance, Thermo Fisher Scientific is developing cutting edge CRISPR technology for providing better efficiency and accuracy in research, and to fulfil the unmet demands in research and therapeutics. Additionally, contribution by the research organization and universities are tremendous creating high impact in the market. For instance, in November 2015, a new CRISPR technology was developed by scientists at the University of Massachusetts Medical School. This technology help in the genome editing at specific target location.
The Global Genome Editing/Genome Engineering market is segmented on the basis of base technology, product, application, end users and region. Based on the base type, the market is divided into CRISPR, TALEN, ZFN, antisense and other technologies. On the basis of product, the market is segmented into reagents & consumables, software & systems and services. Based on the application, the market is divided into animal genetic engineering, plant genetic engineering, diagnostic applications, drug discovery & development and other. Based on the end users, the market is divided into pharmaceutical companies, biotechnology companies, academic & government and research institutes. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 5900.0 Million |
| Revenue Forecast In 2031 | USD 28469.3 Million |
| Growth Rate CAGR | CAGR of 19.20 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Technology, By Products, By Application, By End Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Thermo Fisher Scientific Inc., Merck & Co. Inc, Horizon Discovery group plc, Genscript biotech corporation, Sangamo Therapeutics Inc., lonza group ltd, Editas Medicine Inc, Crispr Therapeutics, Eurofins Scientific Inc, Precision Biosciences Inc, Oxford Genetics Ltd., Intellia Therapeutics Inc, Synthego corporation, Vigene Biosciences Inc, Epigenie, Integrated DNA Technologies Inc, New England Biolabs Inc, Origene Technologies Inc, Transposagen Biopharmaceuticals Inc, and Creative Biogene Inc. among others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Technology
Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Products
Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Application
Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on End Users
Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Region
Europe Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country
North America Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country
Asia Pacific Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country
Latin America Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country
Middle East & Africa Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Genome Editing/Genome Engineering Market Snapshot
Chapter 4. Global Genome Editing/Genome Engineering Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Major Investment, Partnerships and Collaborations in Genomics Research
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. By Technology & Market Share, 2020 & 2028
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following By Technology:
5.2.1. CRISPR
5.2.2. TALEN
5.2.3. ZFN
5.2.4. Antisense
5.2.5. Other Technologies
Chapter 6. Market Segmentation 2: Product Estimates & Trend Analysis
6.1. Product Type & Market Share, 2020 & 2028
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Product Type:
6.2.1. Reagents & Consumables
6.2.2. Software & Systems
6.2.3. Services
Chapter 7. Market Segmentation 3: Application Estimates & Trend Analysis
7.1. Application Type & Market Share, 2020& 2028
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Application Type:
7.2.1. Animal Genetic Engineering
7.2.2. Plant Genetic Engineering
7.2.3. Diagnostic Applications
7.2.4. Drug Discovery & Development
7.2.5. Other
Chapter 8. Market Segmentation 4: End-Users Estimates & Trend Analysis
8.1. End-Users & Market Share, 2020 & 2028
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Academic & Government Research Institutes
Chapter 9. Genome Editing/Genome Engineering Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by By Technology, 2020-2028
9.1.2. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by Product, 2020-2028
9.1.3. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by Application, 2020-2028
9.1.4. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028
9.1.5. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by country, 2020-2028
9.2. Europe
9.2.1. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, 2020-2028
9.2.2. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, 2020-2028
9.2.3. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, 2020-2028
9.2.4. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by End-Users, 2020-2028
9.2.5. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by country, 2020-2028
9.3. Asia Pacific
9.3.1. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, 2020-2028
9.3.2. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, 2020-2028
9.3.3. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, 2020-2028
9.3.4. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by End-Users, 2020-2028
9.3.5. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by country, 2020-2028
9.4. Latin America
9.4.1. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, (US$ Million)
9.4.2. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, (US$ Million)
9.4.3. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, (US$ Million)
9.4.4. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by country, (US$ Million) 2020-2028
9.5. Middle East & Africa
9.5.1. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, (US$ Million)
9.5.2. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, (US$ Million)
9.5.3. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, (US$ Million)
9.5.4. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by country, (US$ Million) 2020-2028
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc.
10.2.2. Merck & Co. Inc
10.2.3. Horizon Discovery group plc
10.2.4. Genscript biotech corporation
10.2.5. Sangamo Therapeutics Inc.
10.2.6. lonza group ltd
10.2.7. Editas Medicine Inc
10.2.8. Crispr Therapeutics
10.2.9. Eurofins Scientific Inc
10.2.10. Precision Biosciences Inc
10.2.11. Oxford Genetics Ltd.
10.2.12. Intellia Therapeutics Inc
10.2.13. Synthego corporation
10.2.14. Vigene Biosciences Inc
10.2.15. Epigenie
10.2.16. Integrated DNA Technologies Inc
10.2.17. New England Biolabs Inc
10.2.18. Origene Technologies Inc
10.2.19. Transposagen Biopharmaceuticals Inc
10.2.20. Creative Biogene Inc
10.2.21. Other Prominent Player